Insider Buying: Advanced Oncotherapy PLC (AVO) Insider Acquires 100,000 Shares of Stock
Advanced Oncotherapy PLC (LON:AVO) insider Enrico Cipro Vanni acquired 100,000 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The shares were bought at an average price of GBX 18 ($0.24) per share, with a total value of £18,000 ($23,743.57).
Shares of Advanced Oncotherapy PLC (AVO) opened at 16.25 on Tuesday. The stock’s market cap is GBX 11.78 million. Advanced Oncotherapy PLC has a one year low of GBX 11.00 and a one year high of GBX 149.00. The stock’s 50 day moving average price is GBX 14.91 and its 200-day moving average price is GBX 34.09.
COPYRIGHT VIOLATION WARNING: This news story was originally published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/08/01/insider-buying-advanced-oncotherapy-plc-avo-insider-acquires-100000-shares-of-stock.html.
Advanced Oncotherapy PLC Company Profile
Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property.
Receive News & Ratings for Advanced Oncotherapy PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy PLC and related companies with MarketBeat.com's FREE daily email newsletter.